Cleared Abbreviated

K011866 - OXYHEAL 2000 HYPERBARIC CHAMBER SERIES, MODEL OXYHEAL 2000 SERIES

K011866 is an FDA 510(k) clearance for OXYHEAL 2000 HYPERBARIC CHAMBER SERIES, manufactured by Hyperbaric Technologies, Inc.. The device is a Class 2 Anesthesiology device with product code CBF cleared through the Abbreviated 510(k) pathway after a 357-day FDA review.

K011866 · Hyperbaric Technologies, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2002
Decision
357d
Days
Class 2
Risk

K011866 is an FDA 510(k) clearance for the OXYHEAL 2000 HYPERBARIC CHAMBER SERIES, MODEL OXYHEAL 2000 SERIES. Classified as Chamber, Hyperbaric (product code CBF), Class II - Special Controls.

Submitted by Hyperbaric Technologies, Inc. (National City, US). The FDA issued a Cleared decision on June 6, 2002 after a review of 357 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5470 - the FDA anesthesiology and respiratory device framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Hyperbaric Technologies, Inc. devices

FDA 510(k) Submission Details - K011866

510(k) Number K011866 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 14, 2001
Decision Date June 06, 2002
Days to Decision 357 days
Submission Type Abbreviated
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
217d slower than avg
Panel avg: 140d · This submission: 357d
Pathway characteristics
Standards-based clearance path.

CBF Device Classification - Class 2, Special Controls

Product Code CBF Chamber, Hyperbaric
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5470
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CBF Chamber, Hyperbaric

All 24
Devices cleared under the same product code (CBF) and FDA review panel - the closest regulatory comparables to K011866.
SECHRIST MONOPLACE HYPERBARIC OXYGEN CHAMBER
K140559 · Sechrist Industries, Inc. · May 2014
SECHRIST MONOPLACE HYPERBARIC OXYGEN CHAMBER
K100268 · Sechrist Industries, Inc. · Apr 2010
MODEL 3300E/ER MONOPLACE HYPERBARIC OXYGEN CHAMBER
K052713 · Sechrist Industries, Inc. · Oct 2005
BARA-MED, ACRYLIC MONOPLACE HYPERBARIC CHAMBER
K993010 · Environmental Tectonics Corp. · May 2000
SIGMA 3400 MONOPLACE HYPERBARIC CHAMBER
K990927 · Perry Baromedical Corp. · Nov 1999
HTU3
K984313 · Hyox Systems , Ltd. · Oct 1999